Search
Search Funnelback University
- Refined by:
- Date: 2023
1 -
10 of
19
search results for lupus
Fully-matching results
-
table-IV.dvi
https://www.mrao.cam.ac.uk/surveys/snrs/table-IV.pdf10 Jan 2023: Table IV – 1 – Detailed listings. G0.0 0.0 Sgr A EastRA: 17h45m44s 1-GHz flux/Jy: 100? Size/arcmin: 3.52.5Dec: –2900′ Spectral index: 0.8? Type: S. Radio: Non-thermal shell, in complex region, interacting with molecular material to the W. -
table-IV.dvi
https://www.mrao.cam.ac.uk/surveys/snrs/table-IV-l.pdf10 Jan 2023: Table IV – 1 – Detailed listings. G0.0 0.0 Sgr A East. RA: 17h45m44s 1-GHz flux/Jy: 100? Size/arcmin: 3.52.5Dec: –2900′ Spectral index: 0.8? Type: S. Radio: Non-thermal shell, in complex region, interacting with molecular material to the W. X -
tables.dvi
https://www.mrao.cam.ac.uk/surveys/snrs/tables.pdf20 Feb 2023: 2022 December. – xi –. 2.3.3 X-ray/γ-ray. • H1538–32 a large X-ray source in Lupus, near l = 340, b = 18 was identified as a possible SNRby Riegler, -
tables.dvi
https://www.mrao.cam.ac.uk/surveys/snrs/tables-l.pdf20 Feb 2023: associated radio emission. 2022 December. – xi –. 2.3.3 X-ray/γ-ray. • H1538–32 a large X-ray source in Lupus, near l = 340, b = 18 was identified as a -
Cambridge Enterprise invests in PredictImmune – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/22 Feb 2023: Predictimmune will develop similar predictive tests for other significant diseases, which fall into the same immune-mediated category, including lupus, multiple sclerosis, diabetes mellitus, rheumatoid arthritis and transplantation complications. -
Spin-out PredictImmune appoints new CEO – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/spin-out-predictimmune-appoints-new-ceo/22 Feb 2023: long-term value.”. Immune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common, chronic and incurable, and there is currently no way of knowing whether a patient is -
Cambridge spin-out PredictImmune closes Series B, raising £10m –…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-predictimmune-closes-series-b-raising-10m/22 Feb 2023: areas including systemic lupus erythematosus (SLE). -
New agreement with Cambridge spin-out PredictImmune lets SLE join…
https://www.enterprise.cam.ac.uk/news/new-agreement-with-university-spin-out-predictimmune-allows-product-pipeline-to-include-systemic-lupus-erythematosus/22 Feb 2023: SLE is a form of the autoimmune disease lupus, in which the immune system attacks the patients’ own tissues. ... Whilst lupus can be controlled through lifestyle changes and medical interventions, there is currently no cure. -
Consultation Document on Schema Assumptions
https://www.jbs.cam.ac.uk/wp-content/uploads/2020/08/crs-geac-multiline-data-schema-consultation-document-phase-two-v0.9.pdf9 Jul 2023: p) Kidney disease, renal failure. q) Lupus. r) Mental disorders (including Anxiety, Bipolar Disorder, Depression, Obsessive Compulsive Disorder, Schizophrenia). -
History Of Technology Transfer - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/research/technology-transfer/history-of-technology-transfer/21 Jul 2023: Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for systemic lupus erythematosus (SLE) in 50 years and Abthrax, against infectious anthrax, which has been stockpiled
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.